Myristica fragrans Extract Regulates Gut Microbes and Metabolites to Attenuate Hepatic Inflammation and Lipid Metabolism Disorders via the AhR–FAS and NF-κB Signaling Pathways in Mice with Non-Alcoholic Fatty Liver Disease
暂无分享,去创建一个
H. Zhang | G. Wang | Wei Chen | Zhennan Gu | Jianxin Zhao | Wenyu Zhao | Min Guo | Jun Feng
[1] Gut microbiota–derived metabolite 3-idoleacetic acid together with LPS induces IL-35+ B cell generation , 2022, Microbiome.
[2] Yuting Lei,et al. Berberine improves liver injury induced glucose and lipid metabolic disorders via alleviating ER stress of hepatocytes and modulating gut microbiota in mice. , 2021, Bioorganic & medicinal chemistry.
[3] Do Yup Lee,et al. Lactobacillus lactis and Pediococcus pentosaceus‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease , 2021, Clinical and translational medicine.
[4] N. Everaert,et al. Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis , 2021, Critical reviews in food science and nutrition.
[5] Changtao Jiang,et al. Intestinal hypoxia-inducible factor 2α regulates lactate levels to shape the gut microbiome and alter thermogenesis. , 2021, Cell metabolism.
[6] N. Giribabu,et al. Myristic acid defends against testicular oxidative stress, inflammation, apoptosis: Restoration of spermatogenesis, steroidogenesis in diabetic rats. , 2021, Life sciences.
[7] Wei Chen,et al. Daily intake of Lactobacillus alleviates autistic-like behaviors by ameliorating the 5-hydroxytryptamine metabolic disorder in VPA-treated rats during weaning and sexual maturation. , 2021, Food & function.
[8] Wei Chen,et al. Blautia—a new functional genus with potential probiotic properties? , 2021, Gut microbes.
[9] Wei Chen,et al. The Protective Effect of Myristica fragrans Houtt. Extracts Against Obesity and Inflammation by Regulating Free Fatty Acids Metabolism in Nonalcoholic Fatty Liver Disease , 2020, Nutrients.
[10] P. Calder,et al. Effect of Probiotic Use on Antibiotic Administration Among Care Home Residents: A Randomized Clinical Trial. , 2020, JAMA.
[11] Y. Eguchi,et al. The Signaling Molecule Indole Inhibits Induction of the AR2 Acid Resistance System in Escherichia coli , 2020, Frontiers in Microbiology.
[12] Y. Sanz,et al. Depletion of Blautia Species in the Microbiota of Obese Children Relates to Intestinal Inflammation and Metabolic Phenotype Worsening , 2020, mSystems.
[13] E. Vittinghoff,et al. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. , 2019, The American journal of clinical nutrition.
[14] J. Raes,et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study , 2019, Nature Medicine.
[15] R. Rector,et al. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis , 2018, Nutrition reviews.
[16] Kyongbum Lee,et al. Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages , 2018, Cell reports.
[17] F. Gonzalez,et al. PPARα Mediates the Hepatoprotective Effects of Nutmeg. , 2018, Journal of proteome research.
[18] G. Mithieux. Does Akkermansia muciniphila play a role in type 1 diabetes? , 2018, Gut.
[19] Joseph L Evans,et al. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches , 2018, Redox biology.
[20] D. Macêdo,et al. IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[21] Kouichi Miura,et al. The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease , 2017, Journal of obesity & metabolic syndrome.
[22] W. Pan,et al. Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels , 2017, Molecular medicine reports.
[23] K. Kang,et al. Diarylbutane-type Lignans from Myristica fragrans (Nutmeg) show the Cytotoxicity against Breast Cancer Cells through Activation of AMP-activated Protein Kinase , 2017 .
[24] Pierre Bedossa,et al. Pathology of non‐alcoholic fatty liver disease , 2017, Liver international : official journal of the International Association for the Study of the Liver.
[25] M. Fischbach,et al. Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota. , 2016, Cell host & microbe.
[26] F. Anania,et al. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol. , 2016, Gastroenterology.
[27] F. Bäckhed,et al. Altered Microbiota Contributes to Reduced Diet-Induced Obesity upon Cold Exposure , 2016, Cell metabolism.
[28] Gemma K. Alderton. Tumour immunology: Intestinal bacteria are in command , 2015, Nature Reviews Immunology.
[29] Gemma K. Alderton. Tumour immunology: Intestinal bacteria are in command , 2015, Nature Reviews Cancer.
[30] V. Wong,et al. Nonalcoholic fatty liver disease , 2015, Nature Reviews Disease Primers.
[31] Chih-Jung Chang,et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota , 2015, Nature Communications.
[32] V. Tremaroli,et al. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. , 2015, Cell host & microbe.
[33] T. Dinan,et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis , 2015, Behavioural Brain Research.
[34] Kouichi Miura,et al. TOPIC HIGHLIGHT , 2014 .
[35] J. Hoffman,et al. Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets , 2013, Nature Reviews Gastroenterology &Hepatology.
[36] J. Hoffman,et al. Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets , 2013, Nature Reviews Gastroenterology &Hepatology.
[37] A. Gupta,et al. Chemistry, antioxidant and antimicrobial potential of nutmeg (Myristica fragrans Houtt) , 2013 .
[38] V. Tremaroli,et al. Functional interactions between the gut microbiota and host metabolism , 2012, Nature.
[39] E. Hobeika,et al. Natural Aryl Hydrocarbon Receptor Ligands Control Organogenesis of Intestinal Lymphoid Follicles , 2011, Science.
[40] Jinjin Chen,et al. Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome , 2011, British Journal of Nutrition.
[41] Hyoung‐Chun Kim,et al. Methyleugenol reduces cerebral ischemic injury by suppression of oxidative injury and inflammation , 2010, Free radical research.
[42] D. Seo,et al. AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect. , 2010, Bioorganic & medicinal chemistry letters.
[43] J. Ferrières,et al. Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.
[44] T. J. Zachariah,et al. Fatty acids and leaf amino acids in Myristica fragrans Houtt. and related taxa , 2006 .
[45] A. Akindahunsi,et al. Antioxidant properties of Myristica fragrans (Houtt) and its effect on selected organs of albino rats , 2006 .
[46] O. Hankinson. The aryl hydrocarbon receptor complex. , 1995, Annual review of pharmacology and toxicology.
[47] S. P. Pathak,et al. The component glycerides of nutmeg butter (Myristica fragrans) , 1957 .